189 related articles for article (PubMed ID: 32330664)
1. Expression of the type 1 lysophosphatidic acid receptor in osteoblastic cell lineage controls both bone mineralization and osteocyte specification.
Alioli CA; Demesmay L; Laurencin-Dalacieux S; Beton N; Farlay D; Follet H; Saber A; Duboeuf F; Chun J; Rivera R; Bouvard D; Machuca-Gayet I; Salles JP; Gennero I; Peyruchaud O
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Aug; 1865(8):158715. PubMed ID: 32330664
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid receptor type 1 (LPA1) plays a functional role in osteoclast differentiation and bone resorption activity.
David M; Machuca-Gayet I; Kikuta J; Ottewell P; Mima F; Leblanc R; Bonnelye E; Ribeiro J; Holen I; Vales RL; Jurdic P; Chun J; Clézardin P; Ishii M; Peyruchaud O
J Biol Chem; 2014 Mar; 289(10):6551-6564. PubMed ID: 24429286
[TBL] [Abstract][Full Text] [Related]
3. Absence of the lysophosphatidic acid receptor LPA1 results in abnormal bone development and decreased bone mass.
Gennero I; Laurencin-Dalicieux S; Conte-Auriol F; Briand-Mésange F; Laurencin D; Rue J; Beton N; Malet N; Mus M; Tokumura A; Bourin P; Vico L; Brunel G; Oreffo RO; Chun J; Salles JP
Bone; 2011 Sep; 49(3):395-403. PubMed ID: 21569876
[TBL] [Abstract][Full Text] [Related]
4. Osteocyte- and late osteoblast-derived NOTUM reduces cortical bone mass in mice.
Nilsson KH; Henning P; El Shahawy M; Wu J; Koskela A; Tuukkanen J; Perret C; Lerner UH; Ohlsson C; Movérare-Skrtic S
Am J Physiol Endocrinol Metab; 2021 May; 320(5):E967-E975. PubMed ID: 33749332
[TBL] [Abstract][Full Text] [Related]
5. Loss of Gsα in osteocytes leads to osteopenia due to sclerostin induced suppression of osteoblast activity.
Fulzele K; Dedic C; Lai F; Bouxsein M; Lotinun S; Baron R; Divieti Pajevic P
Bone; 2018 Dec; 117():138-148. PubMed ID: 30266511
[TBL] [Abstract][Full Text] [Related]
6. Conditional Lpar1 gene targeting identifies cell types mediating neuropathic pain.
Rivera RR; Lin ME; Bornhop EC; Chun J
FASEB J; 2020 Jul; 34(7):8833-8842. PubMed ID: 32929779
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic Acid Induces Ligamentum Flavum Hypertrophy Through the LPAR1/Akt Pathway.
Zhou T; Du L; Chen C; Han C; Li X; Qin A; Zhao C; Zhang K; Zhao J
Cell Physiol Biochem; 2018; 45(4):1472-1486. PubMed ID: 29466791
[TBL] [Abstract][Full Text] [Related]
8. LPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study.
Yu X; Zhang Y; Chen H
BMC Cancer; 2016 Nov; 16(1):846. PubMed ID: 27809800
[TBL] [Abstract][Full Text] [Related]
9. Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner.
Pellegrini GG; Morales CC; Wallace TC; Plotkin LI; Bellido T
Nutrients; 2016 Jul; 8(7):. PubMed ID: 27409635
[TBL] [Abstract][Full Text] [Related]
10. LPA induces osteoblast differentiation through interplay of two receptors: LPA1 and LPA4.
Liu YB; Kharode Y; Bodine PV; Yaworsky PJ; Robinson JA; Billiard J
J Cell Biochem; 2010 Mar; 109(4):794-800. PubMed ID: 20069565
[TBL] [Abstract][Full Text] [Related]
11. Osteocyte Death and Bone Overgrowth in Mice Lacking Fibroblast Growth Factor Receptors 1 and 2 in Mature Osteoblasts and Osteocytes.
McKenzie J; Smith C; Karuppaiah K; Langberg J; Silva MJ; Ornitz DM
J Bone Miner Res; 2019 Sep; 34(9):1660-1675. PubMed ID: 31206783
[TBL] [Abstract][Full Text] [Related]
12. Extracellular matrix mineralization promotes E11/gp38 glycoprotein expression and drives osteocytic differentiation.
Prideaux M; Loveridge N; Pitsillides AA; Farquharson C
PLoS One; 2012; 7(5):e36786. PubMed ID: 22586496
[TBL] [Abstract][Full Text] [Related]
13. The LPA1/ZEB1/miR-21-activation pathway regulates metastasis in basal breast cancer.
Sahay D; Leblanc R; Grunewald TG; Ambatipudi S; Ribeiro J; Clézardin P; Peyruchaud O
Oncotarget; 2015 Aug; 6(24):20604-20. PubMed ID: 26098771
[TBL] [Abstract][Full Text] [Related]
14. Constitutive protein kinase A activity in osteocytes and late osteoblasts produces an anabolic effect on bone.
Kao RS; Abbott MJ; Louie A; O'Carroll D; Lu W; Nissenson R
Bone; 2013 Aug; 55(2):277-87. PubMed ID: 23583750
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidic acid enhanced the osteogenic and angiogenic capability of osteoblasts via LPA1/3 receptor.
Chen X; Song Z; Chen R; Tan S; Huang C; Liu Y; Cheng B; Fu Q
Connect Tissue Res; 2019 Mar; 60(2):85-94. PubMed ID: 29447019
[TBL] [Abstract][Full Text] [Related]
16. E11/gp38 selective expression in osteocytes: regulation by mechanical strain and role in dendrite elongation.
Zhang K; Barragan-Adjemian C; Ye L; Kotha S; Dallas M; Lu Y; Zhao S; Harris M; Harris SE; Feng JQ; Bonewald LF
Mol Cell Biol; 2006 Jun; 26(12):4539-52. PubMed ID: 16738320
[TBL] [Abstract][Full Text] [Related]
17. Acute-phase protein serum amyloid A3 is a novel paracrine coupling factor that controls bone homeostasis.
Thaler R; Sturmlechner I; Spitzer S; Riester SM; Rumpler M; Zwerina J; Klaushofer K; van Wijnen AJ; Varga F
FASEB J; 2015 Apr; 29(4):1344-59. PubMed ID: 25491310
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic Acid Mediates Imiquimod-Induced Psoriasis-like Symptoms by Promoting Keratinocyte Proliferation through LPAR1/ROCK2/PI3K/AKT Signaling Pathway.
Kim D; Kim HJ; Baek JO; Roh JY; Jun HS
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639115
[TBL] [Abstract][Full Text] [Related]
19. Altered cleavage plane orientation with increased genomic aneuploidy produced by receptor-mediated lysophosphatidic acid (LPA) signaling in mouse cerebral cortical neural progenitor cells.
McDonald WS; Miyamoto K; Rivera R; Kennedy G; Almeida BSV; Kingsbury MA; Chun J
Mol Brain; 2020 Dec; 13(1):169. PubMed ID: 33317583
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidic acid signaling protects pulmonary vasculature from hypoxia-induced remodeling.
Cheng HY; Dong A; Panchatcharam M; Mueller P; Yang F; Li Z; Mills G; Chun J; Morris AJ; Smyth SS
Arterioscler Thromb Vasc Biol; 2012 Jan; 32(1):24-32. PubMed ID: 22015657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
